Andrew McGregor Consultant Haematologist Newcastle

Andrew McGregor Consultant Haematologist Newcastle

Andrew McGregor Consultant Haematologist Newcastle offers expert care in haematopathology, myeloproliferative neoplasms, and chronic lymphocytic leukaemia. He provides specialist diagnosis and management while also leading services that support patients across Northern England. Andrew combines clinical knowledge with academic excellence to deliver the highest standard of haematology care.

Focus on Clinical Expertise

Dr Andrew McGregor is a Consultant Haematologist at Newcastle Hospitals and an Associate Clinical Lecturer at Newcastle University. Since 2018, he has provided care in haematopathology, myeloproliferative neoplasms, chronic lymphocytic leukaemia, and general haematology. He also supports GPs with advice and guidance. Moreover, he works across hospital and community services to ensure seamless care for patients.

Leadership in Haemato-oncology Services

Andrew leads the Northern England Haemato-oncology Service (NEHODS) and serves as Head of Department for Blood Sciences. In addition, he contributes to the British Society for Haematology Laboratory Interest Group and Haemato-oncology Guidelines Committee. Through these roles, he shapes national standards and improves patient care pathways. His leadership ensures innovation and excellence across diagnostic and clinical services.

Academic Contributions and Research

Andrew McGregor Consultant Haematologist Newcastle also engages in academic research and medical education. He completed a post-graduate diploma in genomic medicine and applies this expertise in diagnostic haematology. He participates in clinical trials and contributes to national guidelines for myeloproliferative neoplasms. Furthermore, he sits on the UK MPN and CML study group, strengthening links between research and practice.

Commitment to Medical Education

Andrew values teaching and mentoring. He completed a post-graduate certificate in medical education and chaired the British Society for Haematology education committee from 2021 to 2024. He also chaired the Northern Region Haematology Group during the same period. As an examiner for the Royal College of Pathologists, he maintains high professional standards. He supervises doctors in training and mentors scientists on the HSST programme.

Patient-Centred Clinical Focus

Clinically, Andrew dedicates his work to patients with myeloproliferative neoplasms and chronic lymphocytic leukaemia. He combines evidence-based treatments with compassionate care. Additionally, he collaborates with colleagues across the UK to deliver clinical trials that bring new therapies to patients sooner. His approach ensures both current best practice and future innovation.